Pavmed (NSDQ:PAVM) announced today that its majority-owned subsidiary Lucid Diagnostics will spin off into a separate public company. In a news release, Pavmed said Lucid Diagnostics intends to spin off if favorable market conditions continue to hold, whether it be through an initial public offering (IPO) or a business combination with a healthcare special purpose acquisition corporation. […]
Otolaryngology/Ear, Nose & Throat (ENT)
Lyra Therapeutics names new chief medical officer
Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Dr. Robert Kern as its new chief medical officer. Kern will remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery at the Northwestern University Feinberg School of Medicine while operating as Lyra’s CMO, according to a […]
Intersect ENT launches Mini sinus implant
Intersect ENT today announced that it has launched its Straight Delivery System with its Propel Mini Sinus Implant. The combination packaging originally received FDA premarket approval in July 2020. The Straight Delivery System (SDS) is an extension of Intersect ENT’s Propel family of implants that is engineered for precise, consistent and easy delivery of the […]
SafKan Health wins FDA clearance for ear-cleaning headset
Tucson-based startup SafKan Health this week announced FDA clearance for its automated ear-cleaning device, OtoSet. Developed to clean impacted earways, OtoSet has irrigation and microsuction technology built into an automated and wearable device. According to the American Academy of Otolaryngology, excessive or impacted earwax is present in 1 in 10 children, 1 in 20 adults, and […]
Ex-Sanovas CEO sentenced to 11+ years in fraud case
Former Sanovas president & CEO Larry Gerrans was sentenced yesterday to 135 months in prison for wire fraud and money laundering in connection with a scheme to defraud the medical device company. U.S. District Judge Edward M. Chen handed down the sentence following a guilty verdict after a two-week trial in San Francisco in January 2020. The […]
Intersect ENT rises on Street-beating Q3
Intersect ENT (NSDQ:XENT) shares ticked up today on third-quarter results that came in ahead of the consensus forecast. The Menlo Park, Calif.-based ear, nose and throat condition treatment developer posted losses of -$11.5 million, or -35¢ per share, on sales of $22.7 million for the three months ended Sept. 30, 2020, for a 10.8% bottom-line gain […]
Medtronic wins FDA clearance for nerve monitoring system, acquires Ai Biomed
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its NIM Vital, and it’s acquired Ai Biomed. NIM Vital is an intraoperative nerve monitoring system designed to allow physicians to identify, confirm and monitor nerve function in an effort to reduce the risk of nerve damage during head and neck surgery, according to a […]
Energous partner NewSound wins FCC approval for hearing aid
Energous (NSDQ:WATT) announced today that its partner NewSound received FCC approval for its WattUp-enabled Primo W hearing aid. NewSound Primo W, a next-generation hearing aid, utilizes Energous’ WattUp radio frequency-based wireless charging technology, which supports small, rounded devices such as behind-the-ear and in-the-ear hearing aids, according to a news release. Along with hassle-free battery recharging, […]
Eargo soars after announcing $141.3M IPO
Hearing device developer Eargo announced today that it priced its initial public offering of common stock at approximately $141.3 million. Beginning trading on the Nasdaq market today under the EAR ticker, shares were trading up 102.22% at $36.40 per share in late-afternoon trading. San Jose, Calif.-based Eargo is offering more than 7.85 million shares of its […]
Intersect ENT to acquire Fiagon for $71.1M
Intersect ENT (NSDQ:XENT) announced today that it entered into an agreement to acquire Fiagon AG Medical Technologies for $71.1 million. The $71.1 million (€60 million) cash deal will see Intersect ENT make an initial $17.8 million (€15 million) payment at the time of closing and further $17.8 (€15 million) annual payments over the following three years. […]
PhotoniCare raises more than $6M
Middle ear imaging technology developer PhotoniCare today filed an SEC Form D to confirm the sale of nearly $6.3 million in equity. Champaign, Ill.-based PhotoniCare, which made the first sale in the new notice offering on Aug. 25, 2020, does not intend for it to last longer than one year. It is not being made […]
